RTGN.US RetinalGenix Technologies Inc

Healthcare Health Care Equipment & Supplies USA Stocks
3.99 USD
Close of Sep 20, 2026
3.20 4.00
Market cap
USD 75.2M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is RTGN.US undervalued?

Graham number

The Graham number of RetinalGenix Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RetinalGenix Technologies Inc fundamental analysis

No fundamental analysis for RetinalGenix Technologies Inc yet.

RetinalGenix Technologies Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RetinalGenix Technologies Inc

RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. The company offers the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time comm…

Full company profile